glp 1 helps with GLP-1 Drugs & What They Do GLP-1 | Summary

Tschop recounted his research with DiMarchi and that of others while he accepted the 2023 Banting Medal for Scientific Achievement at the 2023 American Diabetes Association Scientific Sessions.5 The FDA approved the first GLP-1 agonist, twice-a-day Byetta (exenatide), in 2005.1 Since then, several newer and more powerful medications in the GLP-1 agonist class, such as liraglutide and semaglutide, have received FDA approval for type 2 diabetes, with a higher dose of semaglutide FDA approved for weight loss.2 In mid-2022, the first dual agonist, tirzepetide (a combination of a GLP-1 agonist and a GIP), was FDA approved for type 2 diabetes

Tirzepatide: a promising drug for type 2 diabetes and beyond

10.1007/s12630-023-02549-5 [DOI] [PubMed] [Google Scholar] 36.Nersessian RSF, da Silva LM, Carvalho MAS, Silveira SQ, Abib ACV, Bellicieri FN et al (2024) Relationship between residual gastric content and peri-operative semaglutide use assessed by gastric ultrasound: a prospective observational study

In November 1920 Banting and Best began the process of extracting insulin from islet cells taken from the pancreases of cows and pigs (Hall Jan 2022)